Qidni Labs Inc. (Pre-Seed)

Funding Details
Date Award
May 13, 2024
Vertical
Medtech
Funding URL
View Funding Page

Company Info
Founders
Andrew Mendonca, Morteza Ahmadi
Company Description
Qidni works on implantable artificial kidneys for three million patients with kidney failure (end-stage renal disease). Hemodialysis needs 120L of dialysate per four-hour session of dialysis. Qidni technology works with only a few bags of saline solution that is available in most drug stores.
Market
Human Health
Location
Canada

Links
Back to Home Back to Medtech Deals View Funding Announcement